FI884104A - N-/substituerade alkyliden/-1,2,3,4 -tetrahydro-9-akridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. - Google Patents

N-/substituerade alkyliden/-1,2,3,4 -tetrahydro-9-akridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. Download PDF

Info

Publication number
FI884104A
FI884104A FI884104A FI884104A FI884104A FI 884104 A FI884104 A FI 884104A FI 884104 A FI884104 A FI 884104A FI 884104 A FI884104 A FI 884104A FI 884104 A FI884104 A FI 884104A
Authority
FI
Finland
Prior art keywords
deras
akridinaminer
substituerade
alkyliden
tetrahydro
Prior art date
Application number
FI884104A
Other languages
English (en)
Other versions
FI89478C (fi
FI884104A0 (fi
FI89478B (fi
Inventor
Gregory Michael Shutske
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI884104A0 publication Critical patent/FI884104A0/fi
Publication of FI884104A publication Critical patent/FI884104A/fi
Application granted granted Critical
Publication of FI89478B publication Critical patent/FI89478B/fi
Publication of FI89478C publication Critical patent/FI89478C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI884104A 1987-09-08 1988-09-06 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-/substituerad alkyliden/-1,2,3,4-tetrahydro-9-akridinaminer FI89478C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9393587A 1987-09-08 1987-09-08
US9393587 1987-09-08
US07/223,846 US5013741A (en) 1987-09-08 1988-07-25 N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
US22384688 1988-07-25

Publications (4)

Publication Number Publication Date
FI884104A0 FI884104A0 (fi) 1988-09-06
FI884104A true FI884104A (fi) 1989-03-09
FI89478B FI89478B (fi) 1993-06-30
FI89478C FI89478C (fi) 1993-10-11

Family

ID=26788073

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884104A FI89478C (fi) 1987-09-08 1988-09-06 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-/substituerad alkyliden/-1,2,3,4-tetrahydro-9-akridinaminer

Country Status (16)

Country Link
US (1) US5013741A (fi)
EP (1) EP0306825B1 (fi)
JP (1) JP2641915B2 (fi)
KR (1) KR890005058A (fi)
AU (1) AU620043B2 (fi)
CA (1) CA1334669C (fi)
DE (1) DE3889043T2 (fi)
DK (1) DK167251B1 (fi)
ES (1) ES2053652T3 (fi)
FI (1) FI89478C (fi)
HU (1) HU201017B (fi)
IE (1) IE63027B1 (fi)
IL (1) IL87679A0 (fi)
NO (1) NO883986L (fi)
NZ (1) NZ226054A (fi)
PT (1) PT88444B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868177A (en) * 1988-11-09 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. 1,2,3,4-tetrahydro-1,9-acridinediamines, pharmaceutical compositions and use
JPH02180871A (ja) * 1988-11-16 1990-07-13 Hoechst Roussel Pharmaceut Inc ヒドロキシ―1,2,3,4―テトラヒドロアミノアクリジンおよびその製造法
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
US5175172A (en) * 1988-12-19 1992-12-29 Francois Dietlin Method of alleviating AIDS symptoms and compositions therefor
US5149813A (en) * 1989-06-26 1992-09-22 Hoechst-Roussel Pharmaceuticals Incorporated Process for (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
EP0711166A1 (en) * 1993-07-22 1996-05-15 Warner-Lambert Company Controlled release tacrine drug delivery systems and methods for preparing same
CN108047202B (zh) * 2017-12-20 2021-06-11 东南大学 一种铝离子响应型化合物及其制备方法与应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
US3318896A (en) * 1963-12-05 1967-05-09 Squibb & Sons Inc Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines
US3318895A (en) * 1963-12-05 1967-05-09 Squibb & Sons Inc Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines
BE658695A (fi) * 1964-02-03 1965-07-22
US3580915A (en) * 1968-09-16 1971-05-25 American Home Prod 1,2,3,4-tetrahydrobenzol(b)(1,6)naphthyridine derivatives
US3541066A (en) * 1968-09-16 1970-11-17 American Home Prod 2,3-dihydro-1,4-ethanobenzo(b)(1,5)naphthyridine derivatives
US3647800A (en) * 1970-04-30 1972-03-07 American Home Prod 10-substituted - 1 2 3 4 - tetrahydrobenzo(b)(1 6)naphthyridines useful as cns depressants
US3657233A (en) * 1970-04-30 1972-04-18 American Home Prod 10-morpholino-1 2 3 4-tetrahydrobenzo(b)(1 6)naphthyridine derivatives
US3637706A (en) * 1970-04-30 1972-01-25 American Home Prod 10-(4 - (lower)alkylpiperazino) - 1 2 3 4-tetrahydrobenzo(b)(1 6) naphthyridine derivatives useful as cns depressants
US3674790A (en) * 1970-05-01 1972-07-04 American Home Prod 2,10-disubstituted-1,2,3,4-tetrahydrobenzo(bhq (1,6)naphthyridines useful as cns depressants
ES431307A1 (es) * 1973-11-16 1976-09-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos derivados de quinoleina.
US4108998A (en) * 1976-11-08 1978-08-22 American Home Products Corp. Furo[3,4-b]quinoline derivatives and pharmaceutical compositions and methods employing them
US4575553A (en) * 1984-06-18 1986-03-11 Bristol-Myers Company Antitumor m-AMSA analog
DE3582995D1 (de) * 1984-10-25 1991-07-04 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
DK569087A (da) * 1986-10-31 1988-05-01 Sumitomo Pharma Quinolin-derivater, deres fremstilling og anvendelse
US4762841A (en) * 1987-03-30 1988-08-09 Hoechst-Roussel Pharmaceuticals Inc. Substituted 9-amino-spiro(cycloalkyl(b)quinoline-2,1'cycloalkanes)
US4851536A (en) * 1987-05-07 1989-07-25 American Home Products Corporation Cyclohexylquinolines as inhibitors of interleukin 1
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
EP0319429B1 (en) * 1987-12-03 1994-04-27 Mitsubishi Kasei Corporation 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient

Also Published As

Publication number Publication date
FI89478C (fi) 1993-10-11
JP2641915B2 (ja) 1997-08-20
FI884104A0 (fi) 1988-09-06
DK167251B1 (da) 1993-09-27
FI89478B (fi) 1993-06-30
NZ226054A (en) 1991-08-27
JPH01131160A (ja) 1989-05-24
IE63027B1 (en) 1995-03-22
NO883986D0 (no) 1988-09-07
DE3889043T2 (de) 1994-10-06
NO883986L (no) 1989-03-09
ES2053652T3 (es) 1994-08-01
DE3889043D1 (de) 1994-05-19
AU2193688A (en) 1989-03-09
KR890005058A (ko) 1989-05-11
AU620043B2 (en) 1992-02-13
EP0306825A1 (en) 1989-03-15
PT88444B (pt) 1992-10-30
DK497888A (da) 1989-03-09
DK497888D0 (da) 1988-09-07
HU201017B (en) 1990-09-28
EP0306825B1 (en) 1994-04-13
HUT49332A (en) 1989-09-28
PT88444A (pt) 1989-07-31
CA1334669C (en) 1995-03-07
IL87679A0 (en) 1989-02-28
IE882703L (en) 1989-03-08
US5013741A (en) 1991-05-07

Similar Documents

Publication Publication Date Title
FI895692A0 (fi) Displaysystem som utnyttjar ljusgenomslaepplig skaerm och foerfarande foer framstaellning av detsamma.
FI885052A (fi) Katalysatorsystem, som foerhindrar bildning av svavelvaete och som innehaoller kopparoxid.
FI922454A (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI902248A0 (fi) N-heteroaryl-4-kinolinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI885877A (fi) Fotopolymeriserbar blandning och uppteckningsmaterial som framstaellts av densamma.
FI906139A (fi) Halogenerade olefiner, foerfarande foer framstaellning av dessa och anvaendning av dessa som skadedjursbekaempningsmedel.
FI885152A (fi) Foerfarande foer framstaellning av biologiskt foerstoerbara mikrokapslar som innehaoller vattenloesliga peptider och proteiner och medelst detta foerfarande framstaellda mikrokapslar.
FI903214A0 (fi) Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.
FI905689A0 (fi) 3-aminopyrroler, foerfaranden foer deras framstaellning, och deras anvaendning som laekemedel.
FI882443A (fi) Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI884104A (fi) N-/substituerade alkyliden/-1,2,3,4 -tetrahydro-9-akridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI905702A0 (fi) Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter.
FI904660A0 (fi) Som fungicider anvaendbara substituerade triazoler, deras framstaellning och kompositioner.
FI890098A (fi) Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI873852A0 (fi) Foereningar av 2,3,4,5,6,7-hexahydro-2,7 -metanol-1,5-benzoxazonin, foerfarande foer deras framstaellning och laekemedel, som innehaoller dessa foereningar.
FI902852A0 (fi) Renininhibitoriska peptider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI880628A (fi) Nukleotidanaloger, deras framstaellning och anvaendning.
FI902199A0 (fi) 5-substituerade 3-aryl-isoxazolderivat, deras framstaellning och deras anvaendning som skadedjursbekaempningsmedel.
FI881873A0 (fi) Kondenserade heteroalkylenkinolinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel.
FI893707A0 (fi) Foerfarande foer framstaellning av polymerer och deras anvaendning som stabiliseringsaemne foer formaldehyds vattenloesningar.
FI891409A (fi) Dietylenglykolmonoestrar, foerfaranden foer deras framstaellning och deras framstaellning och deras anvaendning som laekemedel.
FI900102A0 (fi) 7-aryl- ochheteroaryletrar av desacetylforskolin, foerfrande foer deras framstaellning och deras anvaending som laekemedel.
FI885336A (fi) 5,6,7,8-tetrahydro-4h-isoxazolo/4,5/ azepinderivat, deras isomerer och syra-additionssalter.
FI906269A (fi) 2,19-metylenoxi- och 2,19-metylentio -tvaerbundna steroider som aromatas- och 19-hydroxylasinhibitorer.
FI882760A (fi) Fibermatta som mellanskikt mellan golv och golvbelaeggning.

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL, INC.

FG Patent granted

Owner name: HOECHST MARION ROUSSEL INC., INC.

PC Transfer of assignment of patent

Owner name: AVENTIS PHARMACEUTICALS INC.

MA Patent expired